Literature DB >> 25143267

Is home blood pressure monitoring useful in the management of patients with resistant hypertension?

Elizabeth S Muxfeldt1, Guilherme S Barros1, Bianca B Viegas1, Fernanda O Carlos1, Gil F Salles2.   

Abstract

BACKGROUND: Ambulatory blood pressure (BP) monitoring (ABPM) is a cornerstone in resistant hypertension (RHT) management. However, it has higher cost and lower patients' acceptance than home BP monitoring (HBPM). Our objective was to evaluate HBPM usefulness in the management of patients with RHT.
METHODS: A total of 240 patients were submitted to 24-hour ABPM and 5-day HBPM (triplicate morning and evening measurements). Patients with uncontrolled office BP (≥140/90mm Hg) were classified as true RHT (daytime or home BP ≥135/85mm Hg) or white-coat RHT (daytime or home BP <135/85mm Hg), and patients with controlled office BP were classified as masked RHT (daytime or home BP ≥135/85mm Hg) or controlled RHT (daytime or home BP <135/85mm Hg). Sensitivity, specificity, predictive values, and likelihood ratios for HBPM were calculated. Agreement between the procedures was evaluated using kappa coefficients and the Bland-Altman method.
RESULTS: Mean office BP was 157±26/84±16mm Hg, mean daytime BP was 134±18/77±13mm Hg, and mean home BP was 143±20/76±14mm Hg. The ABPM and HBPM diagnoses were 35% and 48%, respectively, for true RHT; 36% and 23%, respectively, for white-coat RHT; 7% and 17%, respectively, for masked RHT; and 22% and 13%, respectively, for controlled RHT. HBPM overestimated systolic BP by 8.8 (95% confidence interval (CI) = 6.8-10.7) mm Hg and diastolic BP by 0.2 (95% CI = -1.0 to 1.4) mm Hg. The specificity, sensitivity, and positive and negative predictive values of HBPM in detecting controlled ambulatory BP were 91%, 55%, 89%, and 59%.
CONCLUSIONS: HBPM presented good agreement with ABPM and can be used as a complementary method in the follow-up of resistant hypertensive patients, particularly in those with controlled ambulatory BPs. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  ambulatory blood pressure monitoring; blood pressure; home blood pressure monitoring; hypertension; resistant hypertension.

Mesh:

Year:  2014        PMID: 25143267     DOI: 10.1093/ajh/hpu145

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  6 in total

Review 1.  Prognostic Importance of Ambulatory Blood Pressure Monitoring in Resistant Hypertension: Is It All that Matters?

Authors:  Claudia R L Cardoso; Gil F Salles
Journal:  Curr Hypertens Rep       Date:  2016-12       Impact factor: 5.369

Review 2.  Resistant Hypertension Updated Guidelines.

Authors:  Irene Chernova; Namrata Krishnan
Journal:  Curr Cardiol Rep       Date:  2019-08-30       Impact factor: 2.931

Review 3.  Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review.

Authors:  Daichi Shimbo; Marwah Abdalla; Louise Falzon; Raymond R Townsend; Paul Muntner
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

4.  7th Brazilian Guideline of Arterial Hypertension: Chapter 13 - Resistant Arterial Hypertension

Authors:  M V B Malachias; C I S Rodrigues; E Muxfeldt; G F Salles; H Moreno; M Gus
Journal:  Arq Bras Cardiol       Date:  2016-09       Impact factor: 2.000

5.  Validity of self blood pressure measurement in the control of the hypertensive patient: factors involved.

Authors:  Arleen De León-Robert; Juan José Gascón-Cánovas; José Joaquín Antón-Botella; Isabel María Hidalgo-García; Carmen López-Alegría; Yoalys Dilvani Pérez-Cabrera; Heidy Merari Campusano-Castellanos
Journal:  BMC Cardiovasc Disord       Date:  2019-07-17       Impact factor: 2.298

6.  Resistant hypertension: Prevalence and profile of patients followed in a university ambulatory.

Authors:  Ana Flávia Moura; José A Moura-Neto; Cibele Isaac Saad Rodrigues; Mariana O Miranda; Tulio Coelho Carvalho; Nathalia Pereira Paschoalin Carvalho; Edison Souza; José A Moura-Jr; Constança Margarida S Cruz
Journal:  SAGE Open Med       Date:  2021-06-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.